Amedisys to Present at the William Blair 2019 Growth Stock Conference

BATON ROUGE, La., May 29, 2019 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer, will present at the William Blair 2019 Growth Stock Conference in Chicago, IL on Wednesday, June 5, 2019.

The presentation will begin at 12:40 p.m. Central Time.  To access a live webcast of the Amedisys presentation, please log on through our website at http://investors.amedisys.com.

About Amedisys:

Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. More than 3,000 hospitals and 65,000 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With more than 21,000 employees in 475 care centers within 38 states and the District of Columbia, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of more than 376,000 patients and clients in need every year. For more information about the Company, please visit: www.amedisys.com.

Contact:Amedisys, Inc.Investor Relations855.259.2046[email protected]

You May Also Be Interested In

• William Blair Starts Clean Harbors (CLH) at Outperform, Adds to Conviction List, 'New Top Pick in Waste'
• Singer-Songwriter Eylsia Nicolas' "O-Pop" Sound Gains Momentum as Global Views Surpass 750 Million, With European Radio Programmers Taking Notice
• FDA Approves Isembyld (apitegromab-mstn), the First and Only Muscle-Targeted Therapy for Spinal Muscular Atrophy, Marking a New Milestone in SMA Treatment